Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial Active — Not Recruiting Non-phase study NCT01754363

Survivorship of Attune Primary Total Knee Prosthesis

Survivorship of Attune Primary Total Knee Prosthesis — Active Not Recruiting • Non-phase study • NCT01754363.

📅 28 Aug 2026 ⏱ 1 min read
Active — Not Recruiting
Check the registry for current status and eligibility criteria.
Status
Active — Not Recruiting
Phase
Non-phase study
NCT ID
NCT01754363
Start
2013-02-01
Completion
2030-02-01
ClinicaliQ Trial Snapshot
  • Survivorship of Attune Primary Total Knee Prosthesis — Active Not Recruiting • Non-phase study • NCT01754363.
  • Study tracking how long Attune knee replacements last in patients with osteoarthritis over 15 years.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

This post-marketing investigation will evaluate the long term (up to 15 years) survivorship of the Attune Primary Knee Prosthesis in patients with non-inflammatory degenerative joint disease. Data from Subjects who receive one of four knee configurations will be pooled to establish a contemporary dataset. Conditions: Noninflammatory Degenerative Joint Disease Interventions: Attune Primary Total Knee Replacement Lead Sponsor: DePuy International Planned Enrollment: 1542 participants

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn